Home > Insider Trading > Filing (0001140361-16-066055)

Filing Details

Accession Number:: 0001140361-16-066055
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-05-17 18:05:47
Reporting Period:: 2016-05-09

Filing Date:: 2016-05-17
Accepted Time:: 2016-05-17 18:05:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1419582	Blue Sphere Corp.	BLSP	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1232118	Lllp Partners Investment Lazarus	3200 Cherry Creek South Drive Suite 670 Denver CO 80209	No	No	Yes	No
1531960	B Justin Borus	3200 Cherry Creek South Drive Suite 670 Denver CO 80209	No	No	Yes	No
1531964	Lazarus Management Co Llc	3200 Cherry Creek South Drive Suite 670 Denver CO 80209	No	No	Yes	No
1539956	Lllp Fund Opportunities Israel Lazarus	3200 Cherry Creek Drive, Suite 670 Denver CO 80209	No	No	Yes	No
1639750	Lllp Ii Fund Opportunities Israel Lazarus	3200 Cherry Creek South Drive Suite 670 Denver CO 80209	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-05-09	50,000	$0.08	58,460,564	No	4	L	Indirect	See Footnotes
Common Stock	Acquisiton	2016-05-10	5,000	$0.08	58,465,564	No	4	L	Indirect	See Footnotes
Common Stock	Acquisiton	2016-05-11	20,000	$0.08	58,485,564	No	4	L	Indirect	See Footnotes
Common Stock	Acquisiton	2016-05-12	51,000	$0.08	58,536,564	No	4	L	Indirect	See Footnotes
Common Stock	Acquisiton	2016-05-16	85,000	$0.08	58,621,564	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	L	Indirect	See Footnotes
No	4	L	Indirect	See Footnotes
No	4	L	Indirect	See Footnotes
No	4	L	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Footnotes

Shares of common stock were purchased directly by Lazarus Israel Opportunities Fund II LLLP ("Lazarus Israel II").
The Price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.078 to $0.0847, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The Price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0827 to $0.0837, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The Price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0811 to $0.0825, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The Price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0804 to $0.0819, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The Price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.075 to $0.079, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
This form is filed jointly by Lazarus Management Company LLC ("Lazarus Management"), Justin B. Borus, Lazarus Israel Opportunities Fund LLLP ("Lazarus Israel I"), Lazarus Israel II and Lazarus Investment Partners LLLP ("Lazarus Partners" and together with Lazarus Israel I and Lazarus Israel II, the "Funds"). The securities reported herein are owned directly by the Funds as follows: (i) Lazarus Israel I owns 41,682,641 shares of common stock and 12,500,000 warrants; (ii) Lazarus Israel II owns 8,138,447 shares of common stock and 2,727,273 warrants; and (iii) Lazarus Partners owns 8,800,476 shares of common stock and 2,272,728 warrants. Lazarus Management is the investment adviser and general partner of the Funds and Mr. Borus is the manager of Lazarus Management.
Each of Lazarus Management and Mr. Borus expressly disclaims beneficial ownership of the securities held by the Funds except to the extent of his or its pecuniary interest therein. Each of the Funds expressly disclaims beneficial ownership of the shares held by the other Funds. The filing of this Form 4 shall not be construed as an admission that either Lazarus Management or Mr. Borus, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein.